Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

PARP Inhibitors: To Combine or Not Combine; That Is the Question

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Introduction: PARP inhibitors so far
Johann S. de Bono
Inst. of Cancer Research, Sutton, United Kingdom
from AACR Annual Meeting 2017 on April 3, 2017 1:00 PM-2:45 PM
Mechanism-driven combinatorial therapy of inhibitors of PARP inhibitor and other kinases
Mien-Chie Hung
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2017 on April 3, 2017 1:00 PM-2:45 PM
The study of PARPi resistance using genetically engineered mouse models for BRCA1/2-mutated breast cancer
Sven Rottenberg
University of Bern, Bern, Switzerland
from AACR Annual Meeting 2017 on April 3, 2017 1:00 PM-2:45 PM
Rationally combining PARP inhibitors with DNA-damaging agents: Will it be possible?
Ruth Plummer
Newcastle Univ., Newcastle Upon Tyne, United Kingdom
from AACR Annual Meeting 2017 on April 3, 2017 1:00 PM-2:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4